On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate ...

In 2019, Michael Rosenblum received an experimental new prostate cancer treatment after the disease spread to his ... as a breakthrough when Dr. Morris presented the results in June 2021 at the annual ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

The trial also showed that adding the drug to standard treatment slowed progression of prostate cancer. Dr. Morris presented the results in June 2021 at the annual meeting of the American Society of ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...

"Research on sexual outcomes in prostate cancer survivors has focused on the restoration of erections after treatment," notes a new peer-reviewed article by William Kinnaird and others.

which treatment to use and when is both an art and a science." The article covered facts that men and their doctors should know, including: Approximately 1.5 million new cases of prostate cancer ...

The 5-day radiation method is a new treatment type for prostate cancer. It’s performed using ultrahypofractionated radiation (also known as SBRT). The advantages of ultrahypofractionated ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from UCSF ... Sponsored Researchers found that between 2011 and 2021, the number of ...

CEO of Bayer UK & Ireland, Antonio Payano, said: “We are delighted that men with prostate cancer in England will have early access to another innovative treatment option.